Yayın:
Gut Microbiome Alteration after Reboxetine Administration in Type-1 Diabetic Rats

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAydın, Sinem
dc.contributor.authorTURAN YÜCEL, NAZLI
dc.contributor.authorKARACA ATSAROS, HÜLYA
dc.contributor.authorHülya Karaca
dc.contributor.orcid0000-0002-0484-7191
dc.contributor.orcid0000-0002-0921-5863
dc.contributor.orcid0000-0002-0371-2703
dc.contributor.orcid0000-0002-6578-1341
dc.date.accessioned2025-11-13T10:55:02Z
dc.date.issued2021-09-14
dc.identifier.doihttps://doi.org/10.3390/microorganisms9091948
dc.identifier.endpage1948
dc.identifier.issn2076-2607
dc.identifier.issue9
dc.identifier.openalexW3200941282
dc.identifier.startpage1948
dc.identifier.urihttps://hdl.handle.net/11421/5653
dc.identifier.urihttps://doi.org/10.3390/microorganisms9091948
dc.identifier.volume9
dc.language.isoen
dc.relation.ispartofMicroorganisms
dc.rightsopenAccess
dc.subjectGut flora
dc.subjectReboxetine
dc.subjectBacteroidetes
dc.subjectType 2 diabetes
dc.subjectFirmicutes
dc.subjectVildagliptin
dc.subjectMicrobiome
dc.subjectPharmacology
dc.subjectLactobacillus
dc.subjectDiabetes mellitus
dc.subjectStreptozotocin
dc.subjectMedicine
dc.subjectAcarbose
dc.subjectPrediabetes
dc.subjectInternal medicine
dc.subjectEndocrinology
dc.subjectChemistry
dc.subjectBiology
dc.subjectSerotonin
dc.subjectBioinformatics
dc.subjectReuptake inhibitor
dc.subjectFood science
dc.subjectBiochemistry
dc.subjectFermentation
dc.subjectImmunology
dc.subject.sdg3
dc.titleGut Microbiome Alteration after Reboxetine Administration in Type-1 Diabetic Rats
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5101851867
local.authorid.openalexA5018664863
local.authorid.openalexA5003119292

Dosyalar

Koleksiyonlar

Publications